岭南

Guangdong Lingnan Pharmaceutical Co., Ltd. is a specialized Chinese pharmaceutical company primarily focused on the oncology and anti-infective therapeutic areas. Founded in 1993 and headquartered in Foshan, Guangdong, the company has developed a robust portfolio of high-quality generic medications, particularly cytotoxic agents for cancer treatment. Their manufacturing capabilities include GMP-certified facilities for lyophilized powder injections, liquid injections, and various oral dosage forms. Key products in their commercial catalog include paclitaxel, oxaliplatin, and gemcitabine, which are widely utilized in clinical settings across China. In addition to finished dosage forms, the company also produces active pharmaceutical ingredients (APIs), ensuring a vertically integrated supply chain for its core products. Lingnan Pharmaceutical is recognized as a National High-tech Enterprise and continues to invest in the optimization of drug delivery systems and manufacturing processes.